Intrommune Therapeutics is a specialty biopharmaceutical company located in New York, NY. Intrommune is developing a revolutionary new treatment platform for food allergies that is safe, effective and convenient.

Biotechnology

Intrommune

Intrommune's headquarters in New York, NY, United States

Michael Nelson

Christopher R. Schuster

Wendy Perrow

Stuart Loesch

Jotin Marango

Tonya Winders

Greg Plunkett

Mark Durham

Greg Van Gasse

Jack Levitt

Terrence O. Tormey

Moises V. Vela

Gerard Kugel

Sharon Chinthrajah

Saul Fink

Lara Gross

William Reisacher

Danya Glabau

The Advisory Team at Intrommune Therapeutics brings together experts in business, science, dentistry, and medicine to provide strategic guidance and specialized knowledge that supports the development and commercialization of innovative food allergy treatments. Their combined expertise ensures that Intrommune's therapeutic platform is both scientifically sound and market-ready.

Advisory Team

The Leadership Team at Intrommune Therapeutics directs the strategic vision and operational execution of the company’s innovative treatment platform for food allergies. Comprised of key executives including the COO, CEO, and President, this team collaborates to drive research, ensure regulatory compliance, manage resources, and foster partnerships that enhance the company’s mission to deliver safe and effective therapies.

Leadership Team

Intrommune

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Intrommune

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Related companies